Global Sulphonamides Market Trends, Size, Competitive Analysis and Forecast 2019-2025
The global sulphonamides market is estimated to grow at a CAGR of nearly 4.0% during the forecast period. Rising prevalence of infectious diseases is primarily driving the demand for sulphonamides as an antimicrobial to inhibit bacterial growth. Sulphonamides are used for the treatment of several infectious diseases including meningitis, tuberculosis, urinary tract infections (UTIs), and eye infections. Rising demand for contact lens has increased the concerns regarding eye infection. As per the American Academy of Ophthalmology, in the US, approximately one million eye infections that require a trip to the doctor or hospital happen annually, several of these infections are related to the use of contact lens.
To Request a Sample of our Report on Global Sulphonamides Market: https://www.omrglobal.com/request-sample/sulphonamides-market
As per the Centers for Disease Control and Prevention (CDC), in the US,
nearly 45 million people wear contact lenses. Wearing a contact lens is a major
risk factor for microbial keratitis, a corneal infection caused by bacteria. In
addition, poor hygiene is a major risk factor for several eye complications,
such as microbial keratitis and another contact lens–associated inflammation.
This results in the adoption of topical sulphonamides as an anti-infectives for
the treatment of infections of the eye. It can be applied as an eye drop or
ointment to stop bacterial growth. Doctors generally recommend to not wear
contact lens while using this medication.
Rising prevalence of urinary tract infections is further encouraging the demand for sulphonamides. Increasing ageing population is among the major causes of UTIs among individuals. However, it can affect people of all age group. As per the World Health Organization (WHO), urinary tract infection (UTI) is the major cause of morbidity and healthcare spending among all age group individuals. An estimated 40%-50% of women witnessed having UTI at some point in their lives. This increases the demand for antimicrobials for the treatment of UTIs.
A full Report of Global Sulphonamides Market is Available at: https://www.omrglobal.com/industry-reports/sulphonamides-market
·
Oral
·
Topical
By Application
·
Urinary
Tract Infection
·
Skin
Infection
·
Eye
Infection
·
Respiratory
Tract Infection
·
Gastrointestinal
Tract Infection
·
Others
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of APAC
Rest of The World
- Latin America
- Middle East and Africa
Company
Profiles
·
AA
Pharma Inc.
·
Abbott
Laboratories
·
Allergan
plc
·
Bausch
Health Companies Inc.
·
Bayer
AG
·
Boehringer
Ingelheim International GmbH
·
Cipla
Ltd.
·
DK
Pharmachem Pvt. Ltd.
·
F.
Hoffmann-La Roche AG
·
GlaxoSmithKline
plc
·
Lexine
Technochem Pvt. Ltd.
·
Mylan
N.V.
·
Pfizer
Inc.
·
Prudence
Pharma Chem
·
Teva
Pharmaceutical Industries Ltd.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/sulphonamides-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment